Affinity Investment Advisors, LLC Amgen Inc Transaction History

Affinity Investment Advisors, LLC

$145 Million
Q3 2024

A detailed history of Affinity Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Affinity Investment Advisors, LLC holds 5,170 shares of AMGN stock, worth $1.36 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

5,170

Previous 4,838 6.86%

Holding current value

$1.36 Million

Previous $1.51 Million 10.19%

% of portfolio

1.15%

Previous 1.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$309.38 - $337.38 $102,714 - $112,010	332 Added 6.86%	5,170 $1.67 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $285,083 - $346,451	-1,085 Reduced 18.32%	4,838 $1.51 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $575,919 - $695,207	2,142 Added 56.65%	5,923 $1.68 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $164,670 - $185,768	644 Added 20.53%	3,781 $1.09 Million
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $26,238 - $32,575	-120 Reduced 3.68%	3,137 $843,000
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $304,049 - $359,532	-1,419 Reduced 30.35%	3,257 $723,000
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $903 - $1,100	4 Added 0.09%	4,676 $1.13 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $1,374 - $1,746	6 Added 0.13%	4,672 $1.23 Million
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $4,938 - $5,569	-22 Reduced 0.47%	4,666 $1.05 Million
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $45,449 - $50,577	-197 Reduced 4.03%	4,688 $1.14 Million
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $25,216 - $27,895	-115 Reduced 2.3%	4,885 $1.18 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $25,854 - $29,588	-130 Reduced 2.53%	5,000 $1.13 Million
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $7,429 - $8,704	-35 Reduced 0.68%	5,130 $1.09 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $2.58 Million - $2.86 Million	-11,051 Reduced 68.15%	5,165 $1.26 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $40,387 - $47,065	-182 Reduced 1.11%	16,216 $4.04 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $173,320 - $206,393	-801 Reduced 4.66%	16,398 $3.77 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $304,810 - $338,974	-1,299 Reduced 7.02%	17,199 $4.37 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $863,242 - $1.06 Million	-4,364 Reduced 19.09%	18,498 $4.36 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $1.46 Million - $1.94 Million	8,006 Added 53.89%	22,862 $4.64 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $1.44 Million - $1.85 Million	-7,627 Reduced 33.92%	14,856 $3.58 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $745,016 - $892,684	-4,279 Reduced 15.99%	22,483 $4.35 Million
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $2.18 Million - $2.55 Million	-13,053 Reduced 32.78%	26,762 $4.93 Million
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $2.98 Million - $3.36 Million	-16,494 Reduced 29.29%	39,815 $7.56 Million
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $1.69 Million - $1.97 Million	-9,481 Reduced 14.41%	56,309 $11 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $921,817 - $1.04 Million	-4,975 Reduced 7.03%	65,790 $13.6 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $1.86 Million - $2.09 Million	-11,182 Reduced 13.65%	70,765 $13.1 Million
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $83,528 - $97,614	-493 Reduced 0.6%	81,947 $14 Million
Q4 2017 Feb 07, 2018	SELL	$168.79 - $188.59 $713,812 - $797,547	-4,229 Reduced 4.88%	82,440 $14.3 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $14.5 Million - $16.6 Million	86,669	86,669 $16.2 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Investment Advisors, LLC with notifications on news.

Account

Affinity Investment Advisors, LLC Amgen Inc Transaction History